UpdatesGeneral Updates
AstraZeneca Pharma India secured approval to market Enhertu for an additional HER2-positive breast cancer indication.
AstraZeneca Pharma India LimitedASTRAZEN · Filed with the exchange
This expands the drug's potential market in India, signaling future revenue growth opportunities.
No comments yet. Be the first.